Skip to main content
. 2017 Jun 6;8:646. doi: 10.3389/fimmu.2017.00646

Figure 2.

Figure 2

Fc-galactosylation does not increase CD20 binding of rituximab-derived IgG isotypes. Target antigen recognition by galactosylated and degalactosylated human IgG1–4 isotypes specific for CD20 analyzed by flow cytometry via titration on CD20+ Raji cells. MFI, median fluorescence intensity; IgG, immunoglobulin gamma.

HHS Vulnerability Disclosure